APOE and obesity due to melanocortin 4 receptor deficiency: In summary, our data demonstrated that ApoE ablation alleviates obesity and dysregulation of glucose metabolism at the expense of inciting chronic inflammation through NLRP3 inflammasome in obesity (Fig. 6m).